GEN.F Overview
Upcoming Projects (GEN.F)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (GEN.F)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (GEN.F)
-
Genmab Announces FDA Approval of Arzerra (ofatumumab) in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL
Tickers: NVS, GEN.F
Occurred on: Aug 31, 2016
Strategic Initiatives (GEN.F)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
